Reeves & Associés have created numerous campaigns for the health care sector across Quebec with a view to increasing awareness of a number of diseases, including rheumatoid polyarthritis, in association with the Quebec division of the Arthritis Society; prostate cancer, in association with the Prostate Cancer Research Foundation of Canada; and osteoporosis, in association with Osteoporosis Quebec.

We have promoted the public benefits of osteopathy to the media for many years through our representation of the Association des Ostéopathes du Québec (ROQ).

We were also responsible for the extensive public relations campaign surrounding the market launch of Cymbalta, a new antidepressant produced by Ely Lilly. We oversaw the publicity aspect of Health Canada’s approval of Humira, produced by Abbott Laboratories, which was the first fully human monoclonal antibody for treatment of rheumatoid polyarthritis; and the use of Activase, produced by Hoffman-Laroche, to treat acute strokes.

We formed a partnership with the Fondation québécoise du cancer to distribute a CD entitled Vaincre le cancer, sponsored by SmithKline Beecham, and oversaw the publication of articles in a wide variety of Quebec media in order to increase public awareness. We were responsible for the launch of Zigg-Eeze, a zinc pastille that significantly reduces cold symptoms.